French drugmaker Sanofi on Monday flagged another delay to a U.S. regulatory decision for its experimental multiple sclerosis drug and reported disappointing results from a late-stage study, sending shares of the company down 2%.

Medetomidine, a veterinary sedative, mixed into fentanyl has sent thousands to hospitals, not only for overdose but for life-threatening withdrawal. It is spreading to other cities.

The local pharmacy used to be the default place to fill prescriptions, but like just about everything else, technology is reshaping how we obtain our medications.

Physicians stand to earn big money when signing up patients for drug trials. And lately, some of those trials have been producing dubious science.

Medications like Ozempic mimic a naturally occurring hormone called glucagon-like peptide-1, or GLP-1, which helps regulate blood sugar and appetite. GLP-1 is primarily secreted from the intestines, but the brain also produces some of the hormone.

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in combination with Roche's drug, Perjeta, for the first-line treatment of patients with a type of breast cancer,

FDA approves Addyi for low sexual desire in postmenopausal women under 65, expanding use beyond premenopausal patients for the first time.

Indiana has launched two new dashboards aimed at tracking drug overdose data and violent crimes. Advocates say the overdose data improves on the states previous dashboard.